Boditech Med Statistics

Total Valuation

Boditech Med has a market cap or net worth of KRW 384.59 billion. The enterprise value is 337.59 billion.

Market Cap	384.59B
Enterprise Value	337.59B

Important Dates

The next estimated earnings date is Wednesday, February 19, 2025.

Earnings Date	Feb 19, 2025
Ex-Dividend Date	Mar 29, 2024

Share Statistics

Boditech Med has 21.98 million shares outstanding. The number of shares has decreased by -0.08% in one year.

Current Share Class	n/a
Shares Outstanding	21.98M
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	36.16%
Owned by Institutions (%)	1.81%
Float	13.90M

Valuation Ratios

The trailing PE ratio is 14.09 and the forward PE ratio is 11.33.

PE Ratio	14.09
Forward PE	11.33
PS Ratio	2.71
PB Ratio	1.83
P/TBV Ratio	1.86
P/FCF Ratio	21.66
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.64, with an EV/FCF ratio of 19.02.

EV / Earnings	12.37
EV / Sales	2.38
EV / EBITDA	8.64
EV / EBIT	11.01
EV / FCF	19.02

Financial Position

The company has a current ratio of 7.12, with a Debt / Equity ratio of 0.03.

Current Ratio	7.12
Quick Ratio	5.12
Debt / Equity	0.03
Debt / EBITDA	0.16
Debt / FCF	0.36
Interest Coverage	81.90

Financial Efficiency

Return on equity (ROE) is 13.22% and return on invested capital (ROIC) is 8.88%.

Return on Equity (ROE)	13.22%
Return on Assets (ROA)	8.21%
Return on Capital (ROIC)	8.88%
Revenue Per Employee	288.93M
Profits Per Employee	55.60M
Employee Count	491
Asset Turnover	0.61
Inventory Turnover	1.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.01% in the last 52 weeks. The beta is -0.65, so Boditech Med's price volatility has been lower than the market average.

Beta (5Y)	-0.65
52-Week Price Change	-7.01%
50-Day Moving Average	16,638.20
200-Day Moving Average	16,667.40
Relative Strength Index (RSI)	52.91
Average Volume (20 Days)	122,096

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Boditech Med had revenue of KRW 141.86 billion and earned 27.30 billion in profits. Earnings per share was 1,242.03.

Revenue	141.86B
Gross Profit	86.58B
Operating Income	30.50B
Pretax Income	32.09B
Net Income	27.30B
EBITDA	38.89B
EBIT	30.50B
Earnings Per Share (EPS)	1,242.03

Full Income Statement

Balance Sheet

The company has 65.61 billion in cash and 6.34 billion in debt, giving a net cash position of 59.27 billion or 2,697.20 per share.

Cash & Cash Equivalents	65.61B
Total Debt	6.34B
Net Cash	59.27B
Net Cash Per Share	2,697.20
Equity (Book Value)	223.01B
Book Value Per Share	9,589.01
Working Capital	119.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 27.50 billion and capital expenditures -9.75 billion, giving a free cash flow of 17.75 billion.

Operating Cash Flow	27.50B
Capital Expenditures	-9.75B
Free Cash Flow	17.75B
FCF Per Share	807.82

Full Cash Flow Statement

Margins

Gross margin is 61.03%, with operating and profit margins of 21.50% and 19.24%.

Gross Margin	61.03%
Operating Margin	21.50%
Pretax Margin	22.62%
Profit Margin	19.24%
EBITDA Margin	27.41%
EBIT Margin	21.50%
FCF Margin	12.51%

Dividends & Yields

This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 1.15%.

Dividend Per Share	200.00
Dividend Yield	1.15%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	16.10%
Buyback Yield	0.08%
Shareholder Yield	1.23%
Earnings Yield	7.10%
FCF Yield	4.62%

Dividend Details

Stock Splits

The last stock split was on April 5, 2017. It was a forward split with a ratio of 1.1.

Last Split Date	Apr 5, 2017
Split Type	Forward
Split Ratio	1.1

Scores

Boditech Med has an Altman Z-Score of 12.28.

Altman Z-Score	12.28
Piotroski F-Score	n/a